WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home EBOLA OUTBREAK About Us Corporate Responsibility Reimbursement Support and Patient Assistance Programs Leadership Board of Directors Executive Committee Our Work How We Operate Code of Conduct Compliance Privacy Transparency and Privacy Internet Privacy Policy Cookie Privacy Commitment Cross Border Policy Employment Privacy & Data Protection Diversity Employee Diversity Supplier Diversity Views and Positions Access and Affordability Access to Investigational Medicines Innovation Quality and Safety Sales and Marketing Responsible Public Policy and Advocacy Our History Our People Featured Stories With international agencies and governments working to contain the world's worst outbreak of the Ebola virus disease, the situation is one that Merck is actively involved in and closely monitoring. According to the Centers for Disease Control and Prevention, more than 17,000 people primarily in Guinea, Liberia, Nigeria, Senegal and Sierra Leone have contracted Ebola virus disease (EVD) since March 2014. This is the biggest outbreak on record with more than 6,400 reported deaths. Caring for those who have been infected with EVD is only part of the challenge. Global health and humanitarian organizations are constrained by working within the challenging health care system and poor infrastructure that are prevalent in Western Africa. Merck Provides Support Merck has provided cash donations to a number of organizations involved in Ebola relief and recovery efforts: International Medical Corps to build, staff and provide training on effective Ebola isolation units and referral systems in the Bong County’s Phebe and C.B. Dunbar Hospitals in Liberia. Direct Relief to help support the transport of medical supplies to the region. Donated Merck products were also included in these shipments. As of February 2015, Direct Relief has sent 40 emergency shipments valued at more than $25 million dollars to more than 1,000 hospitals and clinics in the affected areas. Project Hope to conduct an assessment in Sierra Leone to determine specific strategy to stop the spread of the Ebola virus and prevent future outbreaks. Merck also sent two infectious disease experts who specialize in infection control to join a team of other specialists to advise and conduct a rapid assessment of response and relief efforts on the ground. U.S. Fund for UNICEF to support UNICEF’s response to the Ebola crisis, which focused on controlling the outbreak, reinforcing and ensuring access to essential social services and scaling up prevention and preparedness activities. In addition, Merck Medical Outreach Program partner MAP International shipped donated Merck products in their Medical Mission Packs to partners in Liberia and Sierra Leone to help support the health systems in both countries during the crisis. Learn more about our community involvement programs that focus on solving critical health and social issues. Learn more about Corporate Responsibility at Merck. SHARE: THE EBOLA OUTBREAK: A REPORT FROM THE FRONT LINES Dr. Melvin Kohn, medical director of Adult Vaccines at Merck, traveled to Sierra Leone as part of a field assessment team assembled by Project Hope. Read the blog Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map